According to the Department of Justice, Johnson & Johnson has agreed to pay more than $2.2 billion to settle criminal and civil allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients. The agreement is the third-largest settlement with a drugmaker in U.S. history. Read the full story